Bridging Local Startups to Global Markets with Elia Stupka of Angelini Ventures - Part 1

<p>In this episode, Dr. Elia Stupka, Managing Director of Angelini Ventures, traces his path from early computational biology to venture capital. He describes pioneering days on the Human Genome Project in Cambridge, the startup-like pace of building genome annotation tools and infrastructure, and helping launch Singapore’s fugu genome project with Sydney Brenner. He also contrasts academia’s grant-and-paper incentives with industry’s emphasis on deep validation, then explains how open innovation work at Boehringer Ingelheim and advising startups led him into investing. He outlines Angelini Ventures’ global, evergreen structure, its approach to evaluating biotech/medtech/digital health, his high-risk/high-reward style, and the hands-on post-investment work that drives outcomes, including why the firm built a presence in Singapore and Asia.</p><p>Host: Shamieraah Jamal</p><p>Editor: Dillon Chew</p><p>Podcast Team: Chi Dam, Alefiya Dohadwala, Chelsia Goh</p>